Table 5 |
||
|
Changes in medications among patients taking insulin at baseline, who completed the study |
||
|
Participants |
Medication at baseline |
Medication at 24 weeks |
|
|
||
|
1 |
metformin 2 g, glimepirid 3 mg, insulin 28 units |
metformin 2 g, liraglutide 1.2 mg |
|
2 |
metformin 2 g, glimepirid 3 mg, insulin 28 units |
metformin 2 g, liraglutide 1.8 mg |
|
3 |
metformin 0.85 g, insulin 140 units |
metformin 1.7 g, liraglutide 1.2 mg |
|
4 |
metformin 1,7 g, insulin 60 units |
metformin 1.7 g, liraglutide 1.2 mg |
|
5 |
metformin 1 g, insulin 100 units |
metformin 1 g, liraglutide 0.6 mg |
|
6 |
metformin 2 g, insulin 100 units |
metformin 2 g, liraglutide 1.2 mg |
|
7 |
metformin 2 g, insulin 40 units |
metformin 2 g, liraglutide 1.2 mg |
|
8 |
metformin 2 g, insulin 300 units |
metformin 2 g, liraglutide 1.2 mg |
|
9 |
metformin 1.7 g, insulin 64 units |
metformin 1.7 g, liraglutide 1.2 mg |
|
10 |
metformin 0.85 g, insulin 132 units |
metformin 1.7 g, liraglutide 1.2 mg |
|
11 |
metformin2 g, insulin 70 units |
metformin 2 g, liraglutide 1.8 mg |
|
12 |
metformin 1 g, insulin 72 units |
metformin 1 g, liraglutide 1.2 mg |
|
13 |
insulin 30 units |
metformin 2 g, liraglutide 1.2 mg |
|
|
||
|
Müller et al. Nutrition & Metabolism 2011 8:92 doi:10.1186/1743-7075-8-92 |
||